251 related articles for article (PubMed ID: 19836338)
1. Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.
Bowden TA; Aricescu AR; Nettleship JE; Siebold C; Rahman-Huq N; Owens RJ; Stuart DI; Jones EY
Structure; 2009 Oct; 17(10):1386-97. PubMed ID: 19836338
[TBL] [Abstract][Full Text] [Related]
2. Sizes of interface residues account for cross-class binding affinity patterns in Eph receptor-ephrin families.
Guo FY; Lesk AM
Proteins; 2014 Mar; 82(3):349-53. PubMed ID: 24105818
[TBL] [Abstract][Full Text] [Related]
3. Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5.
Xu K; Tzvetkova-Robev D; Xu Y; Goldgur Y; Chan YP; Himanen JP; Nikolov DB
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14634-9. PubMed ID: 23959867
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.
Qin H; Noberini R; Huan X; Shi J; Pasquale EB; Song J
J Biol Chem; 2010 Jan; 285(1):644-54. PubMed ID: 19875447
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor.
Qin H; Shi J; Noberini R; Pasquale EB; Song J
J Biol Chem; 2008 Oct; 283(43):29473-84. PubMed ID: 18708347
[TBL] [Abstract][Full Text] [Related]
6. Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptor.
Lamberto I; Lechtenberg BC; Olson EJ; Mace PD; Dawson PE; Riedl SJ; Pasquale EB
ACS Chem Biol; 2014 Dec; 9(12):2787-95. PubMed ID: 25268696
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the ligand-binding domain of the promiscuous EphA4 receptor reveals two distinct conformations.
Singla N; Goldgur Y; Xu K; Paavilainen S; Nikolov DB; Himanen JP
Biochem Biophys Res Commun; 2010 Sep; 399(4):555-9. PubMed ID: 20678482
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activity.
Han X; Xu Y; Yang Y; Xi J; Tian W; Duggineni S; Huang Z; An J
PLoS One; 2013; 8(11):e80183. PubMed ID: 24265799
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.
Noberini R; Koolpe M; Lamberto I; Pasquale EB
Pharmacol Res; 2012 Oct; 66(4):363-73. PubMed ID: 22750215
[TBL] [Abstract][Full Text] [Related]
10. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.
Saintigny P; Peng S; Zhang L; Sen B; Wistuba II; Lippman SM; Girard L; Minna JD; Heymach JV; Johnson FM
Mol Cancer Ther; 2012 Sep; 11(9):2021-32. PubMed ID: 22807579
[TBL] [Abstract][Full Text] [Related]
11. Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor.
Lamberto I; Qin H; Noberini R; Premkumar L; Bourgin C; Riedl SJ; Song J; Pasquale EB
Biochem J; 2012 Jul; 445(1):47-56. PubMed ID: 22489865
[TBL] [Abstract][Full Text] [Related]
12. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
[TBL] [Abstract][Full Text] [Related]
13. Unique structure and dynamics of the EphA5 ligand binding domain mediate its binding specificity as revealed by X-ray crystallography, NMR and MD simulations.
Huan X; Shi J; Lim L; Mitra S; Zhu W; Qin H; Pasquale EB; Song J
PLoS One; 2013; 8(9):e74040. PubMed ID: 24086308
[TBL] [Abstract][Full Text] [Related]
14. EphA4 signaling regulates phospholipase Cgamma1 activation, cofilin membrane association, and dendritic spine morphology.
Zhou L; Martinez SJ; Haber M; Jones EV; Bouvier D; Doucet G; Corera AT; Fon EA; Zisch AH; Murai KK
J Neurosci; 2007 May; 27(19):5127-38. PubMed ID: 17494698
[TBL] [Abstract][Full Text] [Related]
15. The first identification of complete Eph-ephrin signalling in ctenophores and sponges reveals a role for neofunctionalization in the emergence of signalling domains.
Krishnan A; Degnan BM; Degnan SM
BMC Evol Biol; 2019 Apr; 19(1):96. PubMed ID: 31023220
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of Eph receptors and ephrins in the cochlear ganglion and eighth cranial nerve of the chick embryo.
Siddiqui SA; Cramer KS
J Comp Neurol; 2005 Feb; 482(4):309-19. PubMed ID: 15669077
[TBL] [Abstract][Full Text] [Related]
17. Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function.
Egea J; Nissen UV; Dufour A; Sahin M; Greer P; Kullander K; Mrsic-Flogel TD; Greenberg ME; Kiehn O; Vanderhaeghen P; Klein R
Neuron; 2005 Aug; 47(4):515-28. PubMed ID: 16102535
[TBL] [Abstract][Full Text] [Related]
18. Chemometrical classification of ephrin ligands and Eph kinases using GRID/CPCA approach.
Myshkin E; Wang B
J Chem Inf Comput Sci; 2003; 43(3):1004-10. PubMed ID: 12767159
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the EphA4 protein tyrosine kinase domain in the apo- and dasatinib-bound state.
Farenc C; Celie PH; Tensen CP; de Esch IJ; Siegal G
FEBS Lett; 2011 Nov; 585(22):3593-9. PubMed ID: 22036717
[TBL] [Abstract][Full Text] [Related]
20. Regulation of axonal EphA4 forward signaling is involved in the effect of EphA3 on chicken retinal ganglion cell axon growth during retinotectal mapping.
Fiore L; Medori M; Spelzini G; Carreño CO; Carri NG; Sanchez V; Scicolone G
Exp Eye Res; 2019 Jan; 178():46-60. PubMed ID: 30237102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
